miR-138, which is highly expressed in the serum and synovial tissues of RA patients, negatively regulates HDAC4 to mediates the activities of NF-κB, PGRN, and RA-related inflammatory cytokines in an acetylation-dependent manner. Here, HDAC4 is linked to rheumatoid arthritis.